FAQ

Truvada

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2018
0102020042018

Related topics

Related topics

3 relations

Broader (3)

Tenofovir disoproxil fumarateemtricitabinetenofovir disoproxil

Related mentions per year

Related mentions per year

1969-2018
1960198020002020
Truvada
Tenofovir disoproxil fumarate
emtricitabine
tenofovir disoproxil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Uncertainty in Online U.S. News Coverage of Truvada.
The purpose of this study was to analyze the frequency of incidents of uncertainty in online news articles about Truvada, a drug… (More)
Is this relevant?
2015
2015
Pre-exposure prophylaxis works--it's time to deliver.
 
Is this relevant?
2014
2014
Two years of Truvada for pre-exposure prophylaxis utilization in the US
INTRODUCTION Truvada® (TVD) was approved in July 2012 by the US FDA for pre-exposure prophylaxis (PrEP) in combination with safer… (More)
  • table 1
Is this relevant?
2012
2012
Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen
BACKGROUND Daily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofovir (TFV… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.
A mainstay of strategies to prevent HIV-1 transmission is to use antiretroviral therapy (ART) for pre-exposure prophylaxis (PrEP… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus SHIV162p3M184V mutant by intermittent prophylaxis with Truvada.
Daily preexposure prophylaxis (PrEP) with Truvada (emtricitabine [FTC] and tenofovir disoproxil fumarate [TDF]) is a novel HIV… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.
HIV continues to spread globally, mainly through sexual contact. Despite advances in treatment and care, preventing transmission… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
BACKGROUND Although antiretroviral therapy improves immune response, some human immunodeficiency virus-infected patients present… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BRITISH HIV ASSOCIATION GUIDELINES British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy
Table of contents 1.0 Introduction 2.0 Methodology 2.1 Basing recommendations on evidence 2.2 Implications for research 2.3 Use… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2008
2008
The prevalence of hepatitis B co-infection in a South African urban government HIV clinic.
OBJECTIVE There are an estimated 350 million hepatitis B carriers worldwide. In South Africa the prevalence of mono-infection… (More)
Is this relevant?